Parameter | Study group | Number | Mean | 95% CI for mean | p-value |
---|---|---|---|---|---|
ALT (U/L) | ART group | 76 | 35.67 | 32.18–39.16 | 0.000* |
Pre-ART group | 76 | 23.97 | 21.38-26.57 | ||
AST (U/L) | ART group | 76 | 36.05 | 32.88–39.23 | 0.000* |
Pre-ART group | 76 | 28.00 | 25.52–30.49 | ||
ALP (U/L) | ART group | 76 | 117.14 | 97.99–136.30 | 0.022* |
Pre-ART group | 76 | 89.45 | 75.27–103.64 | ||
Total protein (g/dL) | ART group | 76 | 7.09 | 6.89–7.30 | 0.007* |
Pre-ART group | 76 | 7.46 | 7.29–7.64 | ||
Total bilirubin (mg/dL) | ART group | 76 | 0.787 | 0.761–0.813 | 0.000* |
Pre-ART group | 76 | 0.660 | 0.649–0.673 | ||
Direct bilirubin (mg/dL) | ART group | 76 | 0.275 | 0.227–0.324 | 0.007* |
Pre-ART group | 76 | 0.188 | 0.149–0.228 | ||
Urea (mg/dL) | ART group | 76 | 19.945 | 18.414–21.477 | 0.875 |
Pre-ART group | 76 | 19.750 | 17.824–21.678 | ||
Creatinine (mg/dL) | ART group | 76 | 0.588 | 0.562–0.614 | 0.016* |
Pre-ART group | 76 | 0.641 | 0.607–0.675 | ||
Hemoglobin (g/dL) | Treatment group | 76 | 15.44 | 14.98–15.91 | 0.245 |
Pre-ART group | 76 | 15.02 | 14.46–15.58 | ||
CD4 count (cells/µL) | ART group | 76 | 428.14 | 367.75–488.53 | 0.362 |
Pre-ART group | 76 | 390.97 | 336.93–445.01 |